Global Endotracheal and Tracheostomy Tube Market – Industry Trends and Forecast to 2029

Global Endotracheal and Tracheostomy Tube Market, By Intubation (Orotracheal Intubation, Nasotracheal Intubation), Type (Regular Tubes, Reinforced/Armoured Tubes, Coated Tubes, Laser Resistant Tubes, Double Lumen Tubes, and Others), Application (Anesthesia, Emergency Treatment, and Others), Patient Type (Adult Patients, Pediatric Patients/Neonates),  End User (Hospitals, Clinics, Ambulatory Surgical Centers, Operating Rooms, Intensive Care Units, Home Care, Paramedics, Standalone Ambulance Services) – Industry Trends and Forecast to 2029

Endotracheal and Tracheostomy Tube Market Analysis and Size

Tracheostomy tubes are used in tracheostomy surgery performed in conditions such as anaphylaxis, laryngeal cancer, chronic lung disease, coma, diaphragmatic dysfunction, laryngectomy, obstructive sleep aspiration, and vocal cord paralysis. The strong growth of the tracheostomy tube segment can be attributed to important benefits such as high accuracy, reduced risk of air pollution and aspiration, avoidance of multiple laryngoscopy and intubation, improved ventilation and accurate tidal volume, and carbon dioxide monitoring at the end of exhalation.

Data Bridge Market Research analyses that the global endotracheal and tracheostomy tube market is expected to grow at a CAGR of 4.61% in the forecast period 2022 to 2029. The market was valued at USD 1.99 billion in 2021, and it would grow upto USD 2.85 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Endotracheal and Tracheostomy Tube Market Scope and Segmentation

Market Definition

The endotracheal tube is a hollow, flexible plastic tube that is placed from the mouth to the trachea when a person cannot breathe on his own. The endotracheal tube is connected to a ventilator that provides the patient with sufficient oxygen. It facilitates surgical air passage and helps the surgeon establish the patient's breathing. Tracheostomy and the resulting tracheostomy tubes are now an integral part of surgery.

Global Endotracheal and Tracheostomy Tube Market Dynamics

Drivers

• Advances in Technology in Healthcare Sector

Technological advances in endotracheal intubation have reduced the risk of tube-related infections and improved product safety. A recent increase in the incidence of mechanical ventilation-related pneumonia (VAP) is most commonly observed in patients who have been on endotracheal tubes or ventilators for more than 48 hours. Manufacturers are focused on developing innovative endotracheal tubes to prevent nosocomial infections. For instance, in February, N8 Medical, LLC submitted a clinical trial device exemption (IDE) to the Food and Drug Administration (FDA) for the first human clinical trial of CeraShield endotracheal tube (ETT).

Opportunities

• Surge in Surgeries

Due to the significant increase in surgery, the demand for endotracheal tubes is increasing. According to the Global Surgery and anesthetic Statistics Report, approximately 313 million surgeries are performed each year, thus creating ample opportunities for the endotracheal and tracheostomy tube market.

• Growing incidence of chronic respiratory diseases

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. According to the World Health Organization (WHO), about 251 million people worldwide suffered from COPD in 2016. Increased smoking and poor air quality, especially in middle-income countries, are major factors leading to increased prevalence of COPD and large patient pools requiring mechanical ventilation by tracheostomy. Increasing incidence of chronic respiratory disease worldwide, especially in developing countries, leads to increased demand for tracheostomy tubes worldwide.

Restraints/Challenges

• Increasing Prevalence of Infections

The increased prevalence of nosocomial infections such as ventilator-related pneumonia is expected to impede the growth of the endotracheal tube market during the forecast period. For instance, according to the National Center for Biotechnology Information, the incidence of ventilator-related pneumonia (VAP) in the United States in November 2017 ranges from 2 to 16 ventilators per 1,000 days.

• Unfavourable reimbursement policies

Inadequate reimbursements for endotracheal and tracheostomy tubes is expected to create a hindrance for the market growth. Hence, altering the regulatory rules and procedures constantly is possibly to determine the market growth rate in the mentioned forecast period.

This endotracheal and tracheostomy tube market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endotracheal and tracheostomy tube market  contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Endotracheal and Tracheostomy Tube Market

The COVID-19 has left an unprecedented global public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the forecast period. Ongoing research is enhancing research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included.

The advent of COVID19 has significantly increased the demand for intratracheal and tracheostomy tubes as dyspnea is a clear indicator of infection and it has boosted market growth. This pandemic paved the way for urgent product approval. For example, US-based Biotechnology N8 has received an emergency use authorization from Health Canada for a CeraSheild endotracheal tube in a COVID 19 patient equipped with a ventilator.

Global Endotracheal and Tracheostomy Tube Market Scope

The global endotracheal and tracheostomy tube market is segmented on the basis of intubation, type, application, patient type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Intubation

• Orotracheal Intubation
• Nasotracheal Intubation

Type

• Regular Tubes
• Reinforced/Armoured Tubes
• Coated Tubes
• Laser Resistant Tubes
• Double Lumen Tubes
• Others

Application

• Anesthesia
• Emergency Treatment
• Others

Patient Type

• Adult Patients
• Pediatric Patients/Neonates

End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Operating Rooms
• Intensive Care Units
• Home Care, Paramedics
• Standalone Ambulance Services

Endotracheal and Tracheostomy Tube Market Regional Analysis/Insights

The endotracheal and tracheostomy tube market is analysed and market size insights and trends are provided by country, intubation, type, application, patient type and end user as referenced above.

The major countries covered in the bone marrow biopsy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is the dominating region for the market. Existence of sophisticated medical system, increased number of visits to emergency room, high acceptance of innovative tracheostomy equipment among medical professionals, wide availability of advanced tracheostomy equipment, and the rise of chronic respiratory disease epidemics are driving the growth of the endotracheal and tracheostomy product industry in North America.

Asia-Pacific region is expected to record the fastest growth during the forecast period. Demand for endotracheal tubes in the region is expected to increase due to an increase in the elderly population with respiratory disease, an increase in the prevalence of ventilator-related pneumonia, and an increase in the number of surgeries for chronic cardiovascular disease.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Endotracheal and Tracheostomy Tube Market Share Analysis

The endotracheal and tracheostomy tube market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endotracheal and tracheostomy tube market .

Key players operating in the endotracheal and tracheostomy tube market include:

• AstraZeneca (UK)
• Boehringer Ingelheim International GmbH (Germany)
• GSK plc (UK)
• Novartis AG (Switzerland)
• CHIESI Farmaceutici SpA (Italy)
• Sunovion Pharmaceuticals Inc.(US)
• Teva Pharmaceutical Industries Ltd (Israel)
• Mylan N.V.(US)
• Orion Oyj.(Finland)
• Merck & Co., Inc (US)
• Grifols, S.A (Spain).
• Abbott (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Vectura Group plc (US)
• Pfizer Inc (US)
• Genentech, Inc. (US)
• Biogen (US)